Health Outcomes Research: What's in a Choice?

Co-Moderator(s)

• 

  Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers)

  Associate Director,
  FDA/CDRH/ Office of Clinical Evidence and Analysis , United States
• 

  Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP

  VP Epidemiology
  Research Triangle Institute
  Barcelona, Spain

Presentations:

• 1:30 PM – 1:45 PM ADT

  Association between angiotensin receptor blocker drug recalls and adverse clinical outcomes in patients with heart failure
  

  Presenting Author: Katie Suda, PharmD, M.S., FCCP (she/her/hers) – University of Pittsburgh
• 1:45 PM – 2:00 PM ADT

  Regulatory and health technology assessment of cell and gene therapies in Europe: convergence or divergence?
  

  Presenting Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
• 2:00 PM – 2:15 PM ADT

  Using a target trial framework to compare the effect of high/low opioid dosing strategies at post-surgical discharge on newly developed opioid use disorder
  

  Presenting Author: Yu-Chia (Sam) Hsu, PharmD, MSc – Department of Pharmaceutical Care & Heath Systems, College of Pharmacy, University of Minnesota
• 2:15 PM – 2:30 PM ADT

  Novel Uses of adaptive Designs to Guide provider Engagement in Electronic Health Records (NUDGE-EHR): a pragmatic adaptive database-randomized trial
  

  Presenting Author: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
• 2:30 PM – 2:45 PM ADT

  Personalizing communication to improve medication adherence using reinforcement learning: a pragmatic randomized trial
  

  Presenting Author: Julie Lauffenburger, PharmD, PhD – BWH Div of Pharmacoepidemiology and Pharmacoeconomics
• 2:45 PM – 3:00 PM ADT

  Treatment Effectiveness of Oral Disease-Modifying Agent in Multiple Sclerosis Adjusting for Adherence Trajectories
  

  Presenting Author: Jieni Li, MPH – University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy